Radiation Therapy Oncology Group 9910: Phase 3 Trial to Evaluate the Duration of Neoadjuvant (NEO) Total Androgen Suppression (TAS) and Radiation Therapy (RT) in Intermediate-Risk Prostate Cancer (PCa)

✍ Scribed by Pisansky, T.M.; Hunt, D.; Gomella, L.G.; Amin, M.B.; Balogh, A.G.; Chinn, D.M.; Seider, M.; Duclos, M.; Rosenthal, S.A.; Sandler, H.M.

• Book ID: 122209270
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 119 KB
• Volume: 87
• Category: Article
• ISSN: 0360-3016
• DOI: 10.1016/j.ijrobp.2013.06.011